Early Data: Moderna COVID-19 Vaccine 94.5% Effective

Moderna's experimental COVID-19 vaccine shows 95% efficacy in trials, using mRNA technology to trigger an immune response. Despite promising results, the rapid spread of COVID-19 in the US strains healthcare resources. Public health measures remain crucial even after vaccine availability, as individual efficacy may vary. Moderna plans to seek FDA emergency approval and aims to produce millions of doses. However, public hesitancy poses a challenge, with surveys indicating uncertainty about vaccine uptake. Vaccinations are expected to start in December, with widespread distribution by mid-2021.

What is the effectiveness rate of Moderna's experimental vaccine according to early findings?

• 95%

• 90%

• 85%

• 100%

What technology does Moderna's vaccine use to prompt an immune response?

• Viral vector

• Protein synthesis

• Messenger RNA

• DNA sequencing

Why are COVID-19 cases spreading rapidly in the US beneficial for scientific research?

• It allows for faster data collection

• It reduces the need for clinical trials

• It increases public awareness

• It decreases the cost of research

What does Dr. Anthony Fauci recommend even after a vaccine becomes available?

• Avoid social distancing

• Abandon all public health measures

• Continue public health measures

• Stop wearing masks

What is one major challenge mentioned regarding the COVID-19 vaccine?

• Getting people to take the vaccine

• Storing the vaccine

• Distributing the vaccine

• Manufacturing the vaccine